4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-037451
Director sold 2,000 shares at an average $43.00 ($85,997)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-06-15 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D |
| HERSHBERG ROBERT Director | 2020-06-15 | Sale | −1,016 | $42.59 | $43,271 | 984 | D |
| HERSHBERG ROBERT Director | 2020-06-15 | Sale | −984 | $43.42 | $42,725 | 0 | D |
| Derivatives | |||||||
| HERSHBERG ROBERT Director | 2020-06-15 | Option exercise · Stock Option (Right to Buy) | −2,000 | 71,000 | D | ||
| Open-market sales · 2,000 sh · avg $43.00 · $85,997 | |||||||
Loading xslF345X03/doc4.xml…